Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats

British Journal of Pharmacology

Volumn 133, Issue 1, 2001, Pages 117-124

  Duarte, Juan ^a   Pérez Palencia, Raquel ^a   Vargas, Felix ^a   Angeles Ocete, Maria ^a   Pérez Vizcaino, Francisco ^b   Zarzuelo, Antonio ^a   Tamargo, Juan ^b  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Antioxidant; Flavonoid; Hypertension; Quercetin; SHR

Indexed keywords

ACETYLCHOLINE; FLAVONOID; ISOPROSTANE; MALONALDEHYDE; NITROPRUSSIDE SODIUM; NORADRENALIN; QUERCETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HEART LEFT VENTRICLE; HEART RATE; HEART VENTRICLE HYPERTROPHY; KIDNEY HYPERTROPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; VASOCONSTRICTION; VASODILATATION;

EID: 0034987459     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704064     Document Type: Article

References (43)

1. A clinical trial of the effects of dietary patterns on blood pressure
2. Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects
3. Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships
4. Vasodilator effects of quercetin in isolated rat vascular smooth muscle
5. Determination of aldehydic lipid peroxidation product: Malonaldehyde and 4-hydroxynonenal
6. The heart in hypertension
7. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscular cells
8. New targets for heart-failure therapy: Endothelin, inflammatory cytokines, and oxidative stress
9. Effects of active oxygen species on intimal proliferation in rat aorta after arterial injury
10. Oxidative stress and cardiovascular disease
11. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats
12. On the mechanism of antithrombotic action of flavonoids
13. Small artery structure in hypertension: Dual processes of remodeling and growth
14. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study
15. Antioxidant flavonols and coronary heart disease risk
16. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands
17. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study
18. Relative bioavalability of the antioxidant flavonoid quercetin from various foods in man
19. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats
20. Endothelium-derived contracting factors in resistence arteries of young spontaneously hypertensive rats before development of overt hypertension
21. Plasma and lipoprotein lipid composition and hepatic antioxidant status in spontaneously hypertensive (SHR) and normotensive (WKY) rats
22. Flavonoid intake and coronary mortality in Finland: A cohort study
23. Are free radicals involved in the pathobiology of human essential hypertension?
24. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension
25. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties
26. Bioavaliability, metabolism and physiological impact of 4-oxo-flavonoids
27. Potentiation of nitric oxide-mediated vasorelaxation by xantine oxidase inhibitors
28. Effect of dietary patterns on ambulatory blood pressure. Results from the dietary approaches to stop hypertension (DASH) Trial
29. 2 like compounds are produced in vivo by humans by a non-cyclooxygenase, free radical catalysed mechanism
30. The isoprostanes. Current knowledge and directions for future research
31. Vascular remodeling
32. Does superoxide underlie the pathogenesis of hypertension?
33. Does oxygen species stimulate vascular smooth-muscle cell growth and proto-oncogen expression
34. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals
35. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic. Role of nitric oxide
36. Influence of the antioxidant quercetin in vivo on the level of nitric oxide determined by electron paramagnetic resonance in rat brain during global ischemia and reperfusion
37. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats: Hydroetbidine microfluorography
38. 2α in the rat
39. Cardiovascular effects of UR8225, a novel potassium channel opener: Comparison with levcromakalim
40. Antioxidant status in controlled and uncontrolled hypertension and its relationship to endothelial damage
41. Vascular endothelium and hypertension
42. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women